Diagnostic Startups Take on Growing Threat of Antibiotic-Resistant Bugs
January 14 2020
DZD featured in WSJ review of emerging diagnostic companies
Read More
Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. coli Donor
October 31 2019
EpiXact uses sequencing to confirm cause of patient death in a clinical trial with wide ranging implications
Read More
HBS Impact – Advancing Diagnostics That Can Save Lives
September 1 2019
DZD featured in Harvard Business School alumni publication on Life Lab ventures
Read More
AI Algorithm to Fight HAI Gets Support with NIH Award
July 10 2019
DZD funding award for hospital-acquired infection technology reviewed by HCIT
Read More
DZD Wins $224K SBIR Grant to Fund HAI Outbreak Analysis Tool
July 10 2019
Award funds development of algorithm for detecting hospital acquired infections from large scale genomic datasets
Read More
BioWorld MedTech Features EpiXact® Launch
June 7 2019
Reporter Liz Hollis profiles DZD plans for hospital acquired infection service
Read More